Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Int J Drug Policy. 2020 Dec 10;90:103050. doi: 10.1016/j.drugpo.2020.103050

Table 4:

Measures of substance use treatment quality extracted from adult drug court evaluations published between January 2008 and July 2018

Type of measurea Measure name Presence of measureb, n (%)
Process measures (n = 68)
 General Treatment organization 32 (47)
Treatment provider discipline 11 (16)
 Screening and monitoring Social needs assessment 39 (57)
Mental health disorder screening 35 (51)
Unhealthy substance use screening 36 (53)
Substance use laboratory testing 45 (66)
 Diagnosis Mental health disorder diagnosis 8 (12)
SUD diagnosis 14 (21)
 Availability of services Psychosocial treatment options 23 (34)
Availability of MAUDc 6 (9)
Availability of MOUDc 17 (25)
 Utilization of services Social interventions delivered 21 (31)
Psychosocial treatment delivered 6 (9)
Utilization of MAUD 0 (0)
Utilization of MOUD 5 (7)
Duration of medication treatment 1 (1)
Connection to primary care 2 (3)
Outcome measures (n = 112)
Program graduation rate 98 (79)
Recidivism 95 (77)
All-cause mortality 1 (1)
Overdose deaths 2 (2)
Retention in care after graduation 7 (6)
a

Measures were selected from the Substance Abuse Mental Health Services Administration, the National Drug Court Institute, the 2014 American Society of Addiction Medicine performance measures and the Office of the Assistant Secretary of Planning and Evaluation review of MAT guidelines

b

We assumed that evaluations included all drug court measures collected and that no reporting, in any form, meant that the measure was not collected

c

MAUD = medications for alcohol use disorder, MOUD = medications for opioid use disorder